Visual compatibility of bivalirudin with selected drugs [3]

American Journal of Health-System Pharmacy

Volumn 61, Issue 17, 2004, Pages 1774-1776

  Hartman, Christian A ^a   Faria, Claudio E ^b   Mago, Kabeer ^a  

^a UMass Memorial Health Center   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DILTIAZEM; DOBUTAMINE; FENTANYL CITRATE; GLUCOSE; HIRULOG; HYDROCORTISONE SODIUM SUCCINATE; INFUSION FLUID; METOPROLOL TARTRATE; MIDAZOLAM; MORPHINE SULFATE; PHENYLEPHRINE; SODIUM CHLORIDE; VERAPAMIL;

DRUG MIXTURE; DRUG STABILITY; DRUG USE; HEART CATHETERIZATION; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 8344219622     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.17.1774     Document Type: Letter

References (3)

1. Angiomax (bivalirudin) package insert. Bedford, OH; The Medicines Company. 2002 Jul 18.
2. Bittl JA, Chaitman BR, Feit F et al. Bivalirudin versus heparin during coronary angioplasty for unstable or post-infarction angina: final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J. 2001; 142: 952-9.
3. Allen LV, Levison RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-43.